NDC 0078-0722

Azopt

Brinzolamide

Azopt is a Ophthalmic Suspension/ Drops in the Human Prescription Drug category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is Brinzolamide.

• Product ID: 0078-0722_4a9f4516-bb9d-49a5-a8c6-fcd82063b63f
• NDC: 0078-0722
• Product Type: Human Prescription Drug
• Proprietary Name: Azopt
• Generic Name: Brinzolamide
• Dosage Form: Suspension/ Drops
• Route of Administration: OPHTHALMIC
• Marketing Start Date: 1998-04-30
• Marketing Category: NDA /
• Application Number: NDA020816
• Labeler Name: Novartis Pharmaceuticals Corporation
• Substance Name: BRINZOLAMIDE
• Active Ingredient Strength: 10 mg/mL
• Pharm Classes: Carbonic Anhydrase Inhibitor [EPC], Carbonic Anhydrase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0078-0722-10

1 BOTTLE in 1 CARTON (0078-0722-10) > 10 mL in 1 BOTTLE

• Marketing Start Date: 2021-12-24
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Azopt" or generic name "Brinzolamide"

NDC	Brand Name	Generic Name
0065-0275	Azopt	brinzolamide
0078-0722	Azopt	brinzolamide
0591-2127	Brinzolamide	Brinzolamide
0781-6014	Brinzolamide	Brinzolamide
24208-464	BRINZOLAMIDE	brinzolamide
63629-8793	Brinzolamide	Brinzolamide
68682-464	BRINZOLAMIDE	brinzolamide